The Redox & Signaling Pharmaceutical Holdings Corporation Elmsford, NY - 10523

The Redox & Signaling Pharmaceutical Holdings Corporation is categorized under in Elmsford, NY and active since 2010.

The Redox & Signaling Pharmaceutical Holdings Corporation was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a business, which does work in the B2B market, and is classified as a , under code number by the NAICS.

If you are seeking more information, feel free to contact Harry Demopoulos at the company’s single location by writing to 8 Westchester Plaza # 133, Elmsford, New York NY 10523 or by phoning (914) 592-3155. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: The Redox & Signaling Pharmaceutical Holdings Corporation
Contact Person: Harry Demopoulos
Address: 8 Westchester Plaza # 133, Elmsford, New York 10523
Phone Number: (914) 592-3155
Annual Revenue (USD): $100.000 to $499.999
Founded: 2010
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category:
Share This Business:

The Redox & Signaling Pharmaceutical Holdings Corporation was started in 2010 to provide professional under the SIC code and NAICS code . Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Harry Demopoulos for inquiries that concern The Redox & Signaling Pharmaceutical Holdings Corporation by calling the company number (914) 592-3155, as your correspondence is most welcome. Additionally, the physical location of the single location of The Redox & Signaling Pharmaceutical Holdings Corporation can be found at the coordinates 41.06707,-73.8141 as well as the street address 8 Westchester Plaza # 133 in Elmsford, New York 10523.

For its online presence, you may visit The Redox & Signaling Pharmaceutical Holdings Corporation’s website at and engage with its social media outlets through on Twitter and on Facebook.